|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/25 | |
| A61P 9/00 | |||
| A61P 17/00 |
| (11) | Number of the document | 2310041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09761776.5 |
| Date of filing the European patent application | 2009-06-12 | |
| (97) | Date of publication of the European application | 2011-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/057263 |
| Date | 2009-06-12 |
| (87) | Number | WO 2009/150214 |
| Date | 2009-12-17 |
| (30) | Number | Date | Country code |
| 61163 P | 2008-06-13 | US |
| (72) |
BRIZZI, Maria Felice, IT
MUCCIOLI, Giampiero, IT
GHIGO, Ezio, IT
|
| (73) |
ALIZE PHARMA,
15, Chemin Du Saquin, Espace Europeen, 69130 Ecully,
FR
|
| (54) | UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE |
| UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE |